CollPlant Biotechnologies (CLGN) Assets Average (2018 - 2025)

CollPlant Biotechnologies' Assets Average history runs 8 years deep, the most recent figure standing at $12.4 million for Q4 2025.

• Quarterly Assets Average rose 32.79% year-over-year to $12.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.4 million (up 32.79% YoY) and the FY2025 annual result came in at $14.7 million, down 44.18% from the prior year.
• Assets Average was $12.4 million for Q4 2025 at CollPlant Biotechnologies, down from $15.8 million in the prior quarter.
• Across five years, Assets Average topped out at $54.3 million in Q3 2021 and bottomed at $5.4 million in Q1 2021.
• A 5-year average of $28.5 million and a median of $24.2 million in 2021 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average jumped 817.14% — and 2024, when it slumped 65.61%.
• CollPlant Biotechnologies' Assets Average stood at $52.4 million in 2021, then declined by 25.3% to $39.2 million in 2022, then tumbled by 56.38% to $17.1 million in 2023, then tumbled by 45.17% to $9.4 million in 2024, then soared by 32.79% to $12.4 million in 2025.
• Business Quant data shows CLGN's Assets Average at $12.4 million in Q4 2025, $15.8 million in Q3 2025, and $9.4 million in Q4 2024.